These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26492201)

  • 1. Colour Vision in Stargardt Disease.
    Vandenbroucke T; Buyl R; De Zaeytijd J; Bauwens M; Uvijls A; De Baere E; Leroy BP
    Ophthalmic Res; 2015; 54(4):181-94. PubMed ID: 26492201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-onset stargardt disease: phenotypic and genotypic characteristics.
    Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
    Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absence of fundus abnormalities in Stargardt disease.
    Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stargardt disease with preserved central vision: identification of a putative novel mutation in ATP-binding cassette transporter gene.
    Fujinami K; Akahori M; Fukui M; Tsunoda K; Iwata T; Miyake Y
    Acta Ophthalmol; 2011 May; 89(3):e297-8. PubMed ID: 20163366
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictors of visual acuity and genotype-phenotype correlates in a cohort of patients with Stargardt disease.
    Miraldi Utz V; Coussa RG; Marino MJ; Chappelow AV; Pauer GJ; Hagstrom SA; Traboulsi EI
    Br J Ophthalmol; 2014 Apr; 98(4):513-8. PubMed ID: 24457364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scotopization and pseudoprotanomaly in blue-yellow/colour vision defects.
    Pinckers A; Marré M
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):593-6. PubMed ID: 1471481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence.
    Abalem MF; Otte B; Andrews C; Joltikov KA; Branham K; Fahim AT; Schlegel D; Qian CX; Heckenlively JR; Jayasundera T
    Am J Ophthalmol; 2017 Dec; 184():181-188. PubMed ID: 29038010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy.
    Testa F; Rossi S; Sodi A; Passerini I; Di Iorio V; Della Corte M; Banfi S; Surace EM; Menchini U; Auricchio A; Simonelli F
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4409-15. PubMed ID: 22661472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Scleral Exposure: A Degenerative Outcome of End-Stage Stargardt Disease.
    Lee W; Zernant J; Nagasaki T; Tsang SH; Allikmets R
    Am J Ophthalmol; 2018 Nov; 195():16-25. PubMed ID: 30055151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early impairment of the full-field photopic negative response in patients with Stargardt disease and pathogenic variants of the ABCA4 gene.
    Abed E; Placidi G; Campagna F; Federici M; Minnella A; Guerri G; Bertelli M; Piccardi M; Galli-Resta L; Falsini B
    Clin Exp Ophthalmol; 2018 Jul; 46(5):519-530. PubMed ID: 29178665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
    Sisk RA; Leng T
    Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.
    Chen Y; Ratnam K; Sundquist SM; Lujan B; Ayyagari R; Gudiseva VH; Roorda A; Duncan JL
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3281-92. PubMed ID: 21296825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical phenotypes and prognostic full-field electroretinographic findings in Stargardt disease.
    Zahid S; Jayasundera T; Rhoades W; Branham K; Khan N; Niziol LM; Musch DC; Heckenlively JR
    Am J Ophthalmol; 2013 Mar; 155(3):465-473.e3. PubMed ID: 23219216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full-field ERG as a predictor of the natural course of
    Schroeder M; Kjellström U
    Mol Vis; 2018; 24():1-16. PubMed ID: 29386879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric Inter-Eye Progression in Stargardt Disease.
    Lambertus S; Bax NM; Groenewoud JM; Cremers FP; van der Wilt GJ; Klevering BJ; Theelen T; Hoyng CB
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6824-6830. PubMed ID: 28002570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual colour detection abilities in age-related macular degeneration.
    Shima N; Markowitz SN; Reyes SV
    Can J Ophthalmol; 2013 Aug; 48(4):274-8. PubMed ID: 23931466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The luminance fall in anomaloscope examination: clinical examples.
    Pinckers A; Uvijls A
    Acta Ophthalmol Scand; 2000 Aug; 78(4):465-7. PubMed ID: 10990053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10.
    Kong X; Fujinami K; Strauss RW; Munoz B; West SK; Cideciyan AV; Michaelides M; Ahmed M; Ervin AM; Schönbach E; Cheetham JK; Scholl HPN;
    JAMA Ophthalmol; 2018 Aug; 136(8):920-928. PubMed ID: 29902293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoreceptor Progenitor mRNA Analysis Reveals Exon Skipping Resulting from the ABCA4 c.5461-10T→C Mutation in Stargardt Disease.
    Sangermano R; Bax NM; Bauwens M; van den Born LI; De Baere E; Garanto A; Collin RW; Goercharn-Ramlal AS; den Engelsman-van Dijk AH; Rohrschneider K; Hoyng CB; Cremers FP; Albert S
    Ophthalmology; 2016 Jun; 123(6):1375-85. PubMed ID: 26976702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of widespread retinal dysfunction in patients with stargardt disease and morphologically unaffected carrier relatives.
    Maia-Lopes S; Silva ED; Silva MF; Reis A; Faria P; Castelo-Branco M
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1191-9. PubMed ID: 18326749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.